In ESCC research, FOXO1 can be acetylated, which increases its binding at the IL7R promoter, suppresses IL7R transcription, and inhibits the tumorigenic role of the IL7R [57]. The gene discussed is IL7R; the disease is esophageal squamous cell carcinoma.